Nyrada Inc – Phase I Clinical Trial Dosing Update #2

Highlights:
•Nyrada’s Phase I clinical trial Safety Review Committee (SRC) has considered cumulative safety and pharmacokinetic data, including from the second dosed cohort.
•SRC raised no issues, enabling the clinical trial to proceed to the third cohort.